Financial results - ENGROS-PHARM SRL

Financial Summary - Engros-Pharm Srl
Unique identification code: 4915146
Registration number: J1993001094190
Nace: 4773
Sales - Ron
761.791
Net Profit - Ron
125.328
Employees
8
Open Account
Company Engros-Pharm Srl with Fiscal Code 4915146 recorded a turnover of 2024 of 761.791, with a net profit of 125.328 and having an average number of employees of 8. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Engros-Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 408.345 435.764 476.754 482.489 510.262 540.204 560.748 621.766 696.044 761.791
Total Income - EUR 410.767 435.765 476.755 485.260 510.273 540.362 560.751 621.770 696.048 924.013
Total Expenses - EUR 400.838 433.984 462.774 471.726 487.046 522.482 545.839 595.597 686.163 776.263
Gross Profit/Loss - EUR 9.928 1.781 13.981 13.534 23.227 17.880 14.912 26.174 9.886 147.750
Net Profit/Loss - EUR 8.322 1.476 7.729 8.709 18.124 12.880 9.865 20.640 5.967 125.328
Employees 12 12 10 12 12 11 10 10 9 8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 10.1%, from 696.044 euro in the year 2023, to 761.791 euro in 2024. The Net Profit increased by 119.394 euro, from 5.967 euro in 2023, to 125.328 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Engros-Pharm Srl

Rating financiar

Financial Rating -
ENGROS-PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Engros-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Engros-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Engros-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Engros-Pharm Srl - CUI 4915146

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 77.332 73.473 72.230 68.305 62.519 57.303 52.054 48.565 44.779 0
Current Assets 153.840 127.055 162.482 140.020 168.522 175.166 177.243 168.292 174.642 163.545
Inventories 96.860 83.608 80.992 50.136 68.579 66.065 54.854 64.028 48.339 450
Receivables 49.711 29.512 71.783 82.523 72.927 87.156 88.693 98.289 102.206 148.214
Cash 7.269 13.935 9.707 7.361 27.015 21.945 33.696 5.975 24.096 14.779
Shareholders Funds 63.570 46.583 46.956 50.506 64.870 72.386 76.603 91.398 90.416 126.775
Social Capital 1.350 1.336 1.313 1.289 1.264 1.240 1.213 1.217 1.213 1.206
Debts 167.602 167.921 198.845 161.613 166.170 160.083 152.694 125.459 129.004 36.769
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 163.545 euro in 2024 which includes Inventories of 450 euro, Receivables of 148.214 euro and cash availability of 14.779 euro.
The company's Equity was valued at 126.775 euro, while total Liabilities amounted to 36.769 euro. Equity increased by 36.864 euro, from 90.416 euro in 2023, to 126.775 in 2024.

Risk Reports Prices

Reviews - Engros-Pharm Srl

Comments - Engros-Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.